CrossrefInfokarte
Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis
International Journal of Clinical and Experimental Pathology · 2025
DOI: 10.62347/bnvx1803 ↗Abstract
Kein Abstract verfügbar.
EUVIMED